Project Development Director
Following an undergraduate degree in 1998 in Molecular Biology at the University of Geneva, Switzerland, François completed a Masters degree in Biochemistry as an Erasmus student at the University of Barcelona. This lead to 3 years of basic research in neuroscience at the Jules Gonin Institute of Ophtahlamology in Lausanne Switzerland.
In 2005, François began his career in the pharmaceutical industry as a Clinical Research Assistant in the Division of Oncology at Pierre Fabre Ibérica, working in various phase I, II, and III trials in Lung, Breast, and Bladder Cancer. This lead to a position as Regional Sales Representative for Navelbine oral and IV in Breast and Lung Cancer while completing a Masters in Pharmaceutical Marketing at the Universidad de Pompeu Fabra in Barcelona, Spain. In 2008, he moved to Roche Farma as a Sales Representative for Xeloda, Avastin, Tarceva, and Herceptin in Digestive Tumors. Following this experience, François moved to Eisai Farmaceútica as a Key Account Manager to help in the Spanish launch of Halaven in Metastatic Breast Cancer. A jump to the Medical Department in Eisai allowed François to gain valuable experience in Medical Affairs and drug development for Halaven, Lenvima in Differentiated Thyroid Cancer, and Targretin for Cutaneous T-cell Lymphoma.
François speaks English, Spanish, and French fluently and has acquired a good knowledge of Catalan. In his free time, he enjoys various sports such as Triathlon, Tennis, and Crossfit Training.